Article
Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5'-hydroxylation.
Drug metabolism and disposition: the biological fate of chemicals - 1 Jan 2004
Iida Izumi, Miyata Atsunori, Arai Masayuki, Hirota Mitsuyo, Akimoto Masayuki, Higuchi Shohei, Kobayashi Kaoru, Chiba Kan
Abstract excerpt
The effects of allelic variants of CYP2C9 (CYP2C9*2 and CYP2C9*3) on lornoxicam 5'-hydroxylation were studied using the corresponding variant protein expressed in baculovirus-infected insect cells and human liver microsomes of known genotypes of CYP2C9. The results of the baculovirus expression system showed that CYP2C9.3 gives higher K(m) and lower V(max) values for lornoxicam 5'-hydroxylation than does...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
